REVULVA ALBUM RELEASE NZ TOUR October 31 - November 23. Tickets are on sale from undertheradar.co.nz & *Moshtix for ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

When it comes to food, Americans have much warmer feelings for farmers than they do for retailers or restaurants.

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...

Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Novo Nordisk (NVO – Research Report) yesterday and set a price target of ...

The EP opens with ‘Only One’, where Jack grapples with emotional struggle and longing for completeness amidst a reluctance to ...

Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...

Company actively advancing lead ophthalmology drug candidate to first Investigational New Drug (IND) filingREDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Eyconis, Inc., a biopharmaceutical ...

Healthcare is undervalued despite being a top sector for earnings growth. Read more on attractive investments among ...

The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...

Pfizer Canada commends the provinces and territories for their ... of disease progression by more than half in second-line EGFR-mutated advanced lung cancer Johnson & Johnson announced today that the ...